Treatment of Iron Deficiency Anemia
Start oral ferrous sulfate 200 mg once daily on an empty stomach, add vitamin C 500 mg with each dose to enhance absorption, and continue for 3 months after hemoglobin normalizes to replenish iron stores. 1
Laboratory Interpretation
Your labs confirm severe iron deficiency anemia:
- Hemoglobin 8.4 g/dL (severely low, indicating anemia) 1
- Iron 19 mcg/dL (very low) 1
- TIBC 188 mcg/dL (low-normal, though typically elevated in pure iron deficiency) 2
- Iron saturation 9.96% (severely low, <20% confirms iron deficiency) 3
- Ferritin 81 ng/mL (borderline, but with low iron saturation confirms true iron deficiency) 2
The low TIBC despite iron deficiency suggests possible concurrent inflammation or chronic disease, which complicates the picture. 2
First-Line Oral Iron Therapy
Ferrous sulfate 200 mg once daily is the preferred formulation due to effectiveness and low cost, with each 324 mg tablet containing 65 mg elemental iron. 1, 4
Dosing Strategy
- Take once daily in the morning rather than multiple daily doses to improve tolerance while maintaining effectiveness 1, 5
- Alternate-day dosing (giving 120 mg on alternate days) may maximize absorption and reduce side effects, as daily doses ≥60 mg stimulate hepcidin elevation that persists 24 hours and blocks subsequent absorption 5
- Take on empty stomach for optimal absorption, though taking with food is acceptable if gastrointestinal side effects occur 1
Enhance Absorption
Add ascorbic acid (vitamin C) 500 mg with each iron dose to significantly enhance absorption, particularly critical given your severely low transferrin saturation of 9.96%. 1
Duration
Continue oral iron for 3 months after hemoglobin normalizes to fully replenish iron stores, not just until anemia resolves. 1
Expected Response and Monitoring
- Hemoglobin should rise by approximately 2 g/dL after 3-4 weeks of treatment 1, 3
- Recheck hemoglobin at 4 weeks: If no rise of at least 1.0 g/dL, this identifies patients who should transition to IV iron 6
- Monitor hemoglobin and red cell indices every 3 months for the first year, then again after another year 1
When to Switch to Intravenous Iron
Consider IV iron if any of the following apply:
- Intolerance to at least two different oral iron preparations (try ferrous gluconate or ferrous fumarate if ferrous sulfate not tolerated) 1
- No hemoglobin response (<1.0 g/dL rise) after 4 weeks of oral therapy 1, 6
- Active inflammatory bowel disease with hemoglobin <10 g/dL 1
- Post-bariatric surgery (disrupted duodenal absorption) 1
- Celiac disease with inadequate response despite gluten-free diet 1
- Ongoing gastrointestinal blood loss exceeding oral replacement capacity 1
Ferric carboxymaltose (500-1000 mg single doses) is the preferred IV formulation as it can be delivered within 15 minutes and replaces iron deficits with 1-2 infusions. 1
Identify and Treat Underlying Cause
You must investigate the source of iron deficiency while treating:
For Premenopausal Women
- Assess menstrual blood loss first, as menorrhagia accounts for iron deficiency in 5-10% of menstruating women 1, 3
- Consider pictorial blood loss assessment charts (80% sensitivity/specificity for menorrhagia) 1
For All Patients
- Screen for celiac disease with antiendomysial antibody and IgA measurement, especially in younger patients 1
- Gastrointestinal endoscopy (upper and lower) is indicated for men, postmenopausal women, or if GI symptoms/alarm features present 1
- Evaluate for chronic inflammatory conditions (IBD, chronic kidney disease, heart failure) that may require IV iron as first-line 1, 3
Critical Pitfalls to Avoid
- Do not stop iron when hemoglobin normalizes - continue for 3 months to replenish stores 1
- Do not use multiple daily doses - once-daily or alternate-day dosing is better tolerated with similar or superior efficacy 1, 5
- Do not continue oral iron beyond 4 weeks without response - reassess and switch to IV iron 1, 6
- Do not overlook vitamin C supplementation when oral iron response is suboptimal 1
- Do not fail to identify underlying cause - treating iron deficiency without addressing the source leads to recurrence 1